Aurora Cannabis (ACB) vs Regencell Bioscience (RGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Aurora Cannabis (ACB) has outperformed Regencell Bioscience (RGC) over the past year, losing 1.2% versus a loss of 66.5%. Over five years, RGC leads with a +508.8% price change compared with -93.9% for ACB. Regencell Bioscience is the larger company by market cap ($2.07 billion vs $273.5 million), about 7.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | RGC |
|---|---|---|
| Share price | $4.16 | $4.18 |
| Market cap | $273.50M | $2.07B |
| 1-day change | -2.35% | -4.13% |
| YTD return | -1.42% | -80.10% |
| 1-year return | -1.19% | -66.51% |
| 5-year return | -93.87% | +508.80% |
| EPS (TTM) | $-0.19 | $-0.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-11.70M |
| 52-week high | $6.36 | $69.00 |
| 52-week low | $2.56 | $4.12 |
| Distance from 52-week high | -34.59% | -93.94% |
| Analyst consensus | underperform | — |
| Average volume | 1.31M | 234.51K |
| Shares outstanding | 65.74M | 495.88M |
| Employees | 1,028 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Regencell Bioscience is about 7.6 times larger than Aurora Cannabis by market value ($2.07B vs $273.50M).
- ACB has outperformed RGC by 65.3 percentage points over the past year.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Health Care · Medicinal Chemicals and Botanical Products · 1,028 employees
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
ACB vs RGC FAQ
Which is bigger, Aurora Cannabis or Regencell Bioscience?
Regencell Bioscience (RGC) is larger, with a market capitalization of $2.07B compared with $273.50M for Aurora Cannabis (ACB).
Which stock has performed better over the past year, ACB or RGC?
ACB returned -1.19% over the past 12 months, compared with -66.51% for RGC (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Regencell Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.